Photo of Christine M. Lovly from alkpositive.org
Oct 17, 2023, 16:41
Christine Lovly: Zenocutuzumab (aka Zeno). This is a great Precision Medicine story!
Quoting Christine Lovly, Ingram Associate Professor of Medicine at Vanderbilt University, on X/Twitter:
” Zenocutuzumab (aka Zeno).
- This is a great Precision Medicine story!
- HER2xHER3 bispecific Ab,
- “Dock and Block” MOA,
- Tested in pan-cancer with rare NRG1 fusions.”
For the article click here.
Source: Christine Lovly/Twitter